vs
Dominari Holdings Inc.（DOMH）与凯特制药（NAMS）财务数据对比。点击上方公司名可切换其他公司
Dominari Holdings Inc.的季度营收约是凯特制药的1.6倍（$30.1M vs $19.1M），凯特制药净利率更高（-90.7% vs -438.1%，领先347.4%），凯特制药同比增速更快（740.1% vs 220.4%）
凯特制药是一家美国生物技术企业，专注于研发癌症免疫治疗产品，核心方向为基因工程改造的自体嵌合抗原受体T细胞（CAR-T）疗法，这是一种基于嵌合抗原受体与T细胞的细胞治疗技术。公司成立于2009年，总部位于加利福尼亚州圣莫尼卡，2017年被吉利德科学收购。
DOMH vs NAMS — 直观对比
营收规模更大
DOMH
是对方的1.6倍
$19.1M
营收增速更快
NAMS
高出519.7%
220.4%
净利率更高
NAMS
高出347.4%
-438.1%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $19.1M |
| 净利润 | $-131.8M | $-17.4M |
| 毛利率 | — | — |
| 营业利润率 | -8.9% | -186.1% |
| 净利率 | -438.1% | -90.7% |
| 营收同比 | 220.4% | 740.1% |
| 净利润同比 | -12426.2% | 55.5% |
| 每股收益（稀释后） | $-6.94 | $-0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHNAMS
| Q4 25 | $30.1M | — | ||
| Q3 25 | $50.8M | — | ||
| Q2 25 | $34.1M | $19.1M | ||
| Q1 25 | $8.1M | — | ||
| Q4 24 | $9.4M | $12.8M | ||
| Q3 24 | $4.0M | $29.1M | ||
| Q2 24 | $6.2M | — | ||
| Q1 24 | $1.4M | — |
净利润DOMHNAMS
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | — | ||
| Q2 25 | $16.6M | $-17.4M | ||
| Q1 25 | $-32.5M | — | ||
| Q4 24 | $1.1M | $-92.2M | ||
| Q3 24 | $-4.2M | $-16.6M | ||
| Q2 24 | $-6.1M | — | ||
| Q1 24 | $-5.4M | — |
营业利润率DOMHNAMS
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -57.0% | -186.1% | ||
| Q1 25 | -394.6% | — | ||
| Q4 24 | 0.4% | -338.5% | ||
| Q3 24 | -79.1% | -85.9% | ||
| Q2 24 | -44.3% | — | ||
| Q1 24 | -205.2% | — |
净利率DOMHNAMS
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | — | ||
| Q2 25 | 48.7% | -90.7% | ||
| Q1 25 | -400.5% | — | ||
| Q4 24 | 11.4% | -721.7% | ||
| Q3 24 | -104.2% | -57.2% | ||
| Q2 24 | -99.1% | — | ||
| Q1 24 | -398.0% | — |
每股收益（稀释后）DOMHNAMS
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | — | ||
| Q2 25 | $1.12 | $-0.15 | ||
| Q1 25 | $-3.02 | — | ||
| Q4 24 | $0.21 | $-0.91 | ||
| Q3 24 | $-0.67 | $-0.18 | ||
| Q2 24 | $-1.01 | — | ||
| Q1 24 | $-0.91 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $739.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $778.5M |
| 总资产 | $112.9M | $815.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHNAMS
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | — | ||
| Q2 25 | $28.2M | $739.2M | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $8.2M | $834.2M | ||
| Q3 24 | $7.2M | $422.7M | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $7.1M | — |
股东权益DOMHNAMS
| Q4 25 | $69.4M | — | ||
| Q3 25 | $210.2M | — | ||
| Q2 25 | $88.6M | $778.5M | ||
| Q1 25 | $42.4M | — | ||
| Q4 24 | $39.9M | $757.5M | ||
| Q3 24 | $38.3M | $378.9M | ||
| Q2 24 | $42.4M | — | ||
| Q1 24 | $47.7M | — |
总资产DOMHNAMS
| Q4 25 | $112.9M | — | ||
| Q3 25 | $223.4M | — | ||
| Q2 25 | $109.3M | $815.1M | ||
| Q1 25 | $52.3M | — | ||
| Q4 24 | $47.1M | $864.6M | ||
| Q3 24 | $43.4M | $439.2M | ||
| Q2 24 | $49.1M | — | ||
| Q1 24 | $52.2M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $-37.7M |
| 自由现金流经营现金流 - 资本支出 | — | $-37.8M |
| 自由现金流率自由现金流/营收 | — | -197.2% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-119.7M |
8季度趋势，按日历期对齐
经营现金流DOMHNAMS
| Q4 25 | $22.7M | — | ||
| Q3 25 | $-4.9M | — | ||
| Q2 25 | $-353.0K | $-37.7M | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $-16.7M | $-37.5M | ||
| Q3 24 | $-4.7M | $-12.5M | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $-8.6M | — |
自由现金流DOMHNAMS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-37.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-37.5M | ||
| Q3 24 | — | $-12.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DOMHNAMS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -197.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -293.5% | ||
| Q3 24 | — | -43.2% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DOMHNAMS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DOMHNAMS
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
NAMS
暂无分部数据
